GLP-3 R Phase 2: −28.7%143 Compounds · 5 Layers>98% HPLC All VialsFree Shipping $200+Third-Party Test ReportsResearch Use OnlyCAS Numbers VerifiedGHK-Cu: 4,000+ GenesGLP-3 R Phase 2: −28.7%143 Compounds · 5 Layers>98% HPLC All VialsFree Shipping $200+Third-Party Test ReportsResearch Use OnlyCAS Numbers VerifiedGHK-Cu: 4,000+ Genes
5-Layer Research Architecture

The Full Research Protocol

10 compounds. 5 distinct receptor pathway groups. Every layer independently analyzed with published research backing. For laboratory research use only.

5
Protocol Layers
10
Core Compounds
8+
Distinct Pathways
>98%
HPLC Purity All
Retatrutide (GLP-3 R)
Layer 01

GLP Core

Retatrutide (GLP-3 R)

CAS: 2381089-83-2

−28.7%
Phase 2 (48 wks)
3
Receptor targets
>98%
HPLC purity

Why This Layer

The tri-receptor mechanism (GLP-1R + GIPR + GcgR) produces synergistic effects no single-receptor compound can replicate. Phase 2 showed −28.7% at 48 weeks — the strongest signal in the GLP agonist class.

Mechanism

GLP-1R: appetite suppression + insulin secretion. GIPR: potentiates insulin + attenuates GLP-1 nausea. GcgR: elevated energy expenditure through thermogenic pathway activation.

BPC-157
Layer 02

Gut Recovery

BPC-157

CAS: 137525-51-0

40+
Published studies
15
Amino acids
>98%
HPLC purity

Why This Layer

GLP receptor agonists reduce gastric motility. The gut recovery layer addresses GI mucosal integrity during reduced-intake research phases. BPC-157 has 40+ published studies specifically on GI mucosal mechanisms.

Mechanism

Nitric oxide system modulation, VEGFR2 upregulation, direct mucosal protection effects. Paired with GLP-2 T (Teduglutide) for GLP-2R-mediated epithelial proliferation.

GHK-Cu + SNAP-8
Layer 03

Skin & Glow

GHK-Cu + SNAP-8

CAS: 89030-95-5

4,000+
Gene interactions
3 AA
GHK-Cu size
60+
GHK-Cu studies

Why This Layer

Body composition changes affect skin architecture. GHK-Cu modulates 4,000+ human genes with a bias toward collagen, elastin, and antioxidant upregulation. SNAP-8 targets the complementary SNARE complex pathway.

Mechanism

GHK-Cu: collagen I/III + elastin gene expression, NF-κB anti-inflammatory modulation. SNAP-8: competitive SNARE complex interaction, neuromuscular junction signaling research.

CJC-1295/Ipamorelin + IGF-1 LR3
Layer 04

Lean Mass

CJC-1295/Ipamorelin + IGF-1 LR3

CAS: 863288-34-0

~3×
IGF-1 LR3 t½ vs native
2
GH axis mechanisms
>98%
HPLC purity

Why This Layer

GLP protocols reduce caloric intake. The lean mass layer researches GH axis support during energetic deficit. CJC-1295/Ipamorelin produces synergistic pulsatile GH secretion; IGF-1 LR3 addresses downstream IGF-1R signaling.

Mechanism

CJC-1295: GHRH receptor agonism (GH pulse amplitude). Ipamorelin: GHS-R1a selective agonism (GH pulse frequency). IGF-1 LR3: extended IGF-1R activation (~3× native half-life).

Epithalon + NAD+
Layer 05

Longevity

Epithalon + NAD+

CAS: 307297-39-8

7
Sirtuin targets
4 AA
Epithalon sequence
−50%
NAD+ decline by 60

Why This Layer

The longevity layer addresses cellular aging mechanisms distinct from all other layers. Epithalon targets telomere biology; NAD+ restores sirtuin and PARP substrate. Both decline approximately 50% by age 60 in human tissue studies.

Mechanism

Epithalon: telomerase (TERT) activation in cellular models. NAD+: sirtuin co-substrate (SIRT1–7 deacylation), PARP-1 substrate for DNA repair, electron carrier in mitochondrial respiration.

Source the Full Stack

All 10 protocol compounds. Research-grade quality. >98% HPLC purity. Third-party test reports.